Holen Sie sich die Stockscreener-App
6.9728
26.30%
-2.2672
Schlusskurs vom Vortag:
$9.24
Offen:
$10.51
24-Stunden-Volumen:
1.65M
Relative Volume:
3.51
Marktkapitalisierung:
$44.66M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.96M
KGV:
-0.8009
EPS:
-8.7061
Netto-Cashflow:
$-8.25M
1W Leistung:
-2.71%
1M Leistung:
+88.64%
6M Leistung:
-40.32%
1J Leistung:
+17.92%
1-Tages-Spanne:
$6.5612
$10.81
1-Wochen-Bereich:
$6.5612
$10.81
52-Wochen-Spanne:
$2.07
$19.12
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Firmenname
Quantum Biopharma Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare QNTM vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
6.98 | 59.12M | 0 | -26.96M | -8.25M | -8.7061 |
VRTX
Vertex Pharmaceuticals Inc
|
436.71 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.91 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.47 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
294.95 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.71 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Quantum Biopharma Ltd Aktie (QNTM) Neueste Nachrichten
QNTM Should I Buy - Intellectia AI
Quantum BioPharma Reaches Halfway Point in Patient Enrollment in Imaging Study With MGH - Moomoo
Quantum BioPharma (QNTM) Reports Midpoint Enrollment Milestone in MS Imaging Study - NewMediaWire
Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital - Sahm
symbol__ Stock Quote Price and Forecast - CNN
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Midpoint Enrollment Milestone in MS Imaging Study - TipRanks
Quantum BioPharma (QNTM) Achieves Key Enrollment Milestone in MS Study - GuruFocus
Quantum BioPharma Shares Climb as Multiple Sclerosis Imaging Study Advances (QNTM) - Yahoo Finance
Quantum BioPharma reaches midpoint in MGH MS imaging study - grafa.com
Quantum BioPharma stock surges on MS imaging study progress By Investing.com - Investing.com South Africa
Quantum BioPharma stock surges on MS imaging study progress - Investing.com
Quantum BioPharma Hits Midpoint in MGH Imaging Study as Lucid-MS Advances Toward Phase 2 - TipRanks
Quantum BioPharma (NASDAQ: QNTM) advances MS imaging and Lucid-MS plans - Stock Titan
Quantum BioPharma Ltd. Achieves Halfway Point in Collaborative MS Imaging Study with Massachusetts General Hospital - Quiver Quantitative
Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with ... - Enidnews.com
New MS PET scan in MGH-Quantum trial shows robust myelin damage signals - Stock Titan
QNTM Stock Price, Quote & Chart | QUANTUM BIOPHARMA-B SUB VOT (NASDAQ:QNTM) - ChartMill
Quantum BioPharma Boosts Liquidity and Advances Lucid-MS as U.S. Court Backs Market-Manipulation Suit - TipRanks
Number of shareholders of Quantum Biopharma Ltd. Subordinate Voting Shares Class B – MUN:0K91 - TradingView
Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026 - Stock Titan
Lucid-MS IND filing and longer cash runway at Quantum BioPharma (NASDAQ: QNTM) - Stock Titan
Quantum Biopharma Posts Higher Assets but Swings to Shareholders’ Deficit in Q1 2026 Filing - TipRanks
Quantum BioPharma Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[6-K] Quantum Biopharma Ltd. Current Report (Foreign Issuer) | QNTM SEC FilingForm 6-K - Stock Titan
Quantum BioPharma Provides Corporate Update - The Manila Times
Top Cannabis Stocks To Follow NowApril 27th - MarketBeat
Quantum Biopharma buys additional $1 million of Bitcoin, other cryptocurrencies - MSN
Quantum Biopharma bolsters Bitcoin treasury - MSN
Quantum BioPharma announces private placement - MSN
Cannabis Stocks To Watch NowApril 22nd - MarketBeat
Quantum BioPharma’s Unbuzzd Licensee Names New CEO to Drive U.S. Rollout of Clinically Backed Hangover Beverage - TipRanks
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant - The Manila Times
Unbuzzd’s new CEO to drive U.S. rollout for Quantum BioPharma (NASDAQ: QNTM) - Stock Titan
Quantum BioPharma Ltd. Announces Appointment of Richard Buzbuzian as CEO of Unbuzzd Wellness Inc. to Drive Commercialization of Innovative Beverage - Quiver Quantitative
Hangover remedy maker Unbuzzd picks CEO for rollout in Florida and Texas - Stock Titan
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints - GlobeNewswire
Promising Cannabis Stocks To Follow TodayApril 21st - MarketBeat
Quantum (QNTM) Stock: Momentum Behavior Insight (Slight Rise) 2026-04-20Shared Buy Zones - Cổng thông tin điện tử tỉnh Lào Cai
Press Releases about Royal Bank of Canada (Toronto Stock Exchange:RY) - FinancialContent
Value Recap: Should I invest in Quantum BioPharma Ltd before earnings2026 News Drivers & Technical Buy Zone Confirmation - baoquankhu1.vn
Operating expenses (excl. COGS) of Quantum Biopharma Ltd. Subordinate Voting Shares Class B – HAM:0K91 - TradingView — Track All Markets
Whats the fair value of Quantum BioPharma Ltd stockWeekly Gains Report & Risk Managed Investment Entry Signals - baoquankhu1.vn
Recap Report: Can Quantum BioPharma Ltd generate free cash flow2026 Historical Comparison & Stock Timing and Entry Methods - baoquankhu1.vn
Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements - ACCESS Newswire
Finanzdaten der Quantum Biopharma Ltd-Aktie (QNTM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.25%
0.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):